Yahoo Canada Web Search

Search results

1. • 

     GSK plc (GSK): Is It the Best FTSE Dividend Stock to Buy According to Hedge Funds?

     Insider Monkey via Yahoo Finance Canada· 3 hours ago

     We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we are...

2. • 

     Should We Be Delighted With GSK plc's (LON:GSK) ROE Of 36%?

     Simply Wall St. via Yahoo Finance Canada· 5 days ago

     While some investors are already well versed in financial metrics (hat tip), this article is for...

3. • 

     GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac

     Zacks via Yahoo Finance Canada· 5 days ago

     GSK revamps its existing collaboration deal with partner CureVac, converting it from a collaboration...

4. • 

     Biotech Stock Roundup: GSK, CVAC Revise Agreement, Updates From MRNA, RNAC & More

     Zacks via Yahoo Finance Canada· 5 days ago

     It was a regular week for the biotech sector with quite a few important pipeline and regulatory...

5. • 

     GSK to Pay CureVac Up to €1.4 Billion for Flu, Covid Shots

     Bloomberg· 6 days ago

     Have a confidential tip for our reporters? GSK Plc agreed to pay as much as €1.4 billion ($1.5...

6. • GSK and CureVac to Restructure Collaboration into New Licensing Agreement

     Digital Journal· 6 days ago

     GSK acquires full rights to develop, manufacture and commercialize globally mRNA candidate vaccines for influenza and COVID-19, including combinationsCureVac receives €400 ...

7. • 

     Gilead (GILD) Loses 17.6% YTD: How Should You Play the Stock?

     Zacks via Yahoo Finance Canada· 18 hours ago

     While Gilead (GILD) has been reeling under pressure year to date due to pipeline setbacks, holding...

8. • 

     US inks vaccine deal with Moderna as bird flu threat looms

     Detroit News· 7 days ago

     Moderna Inc. secured nearly $200 million from the US government to speed development of an mRNA...

9. • Increasing Demand Customized Treatment is likely to Boost Necrotizing Fasciitis Treatment Market...

     Digital Journal· 6 days ago

     Necrotizing Fasciitis Treatment Industry is Expected to Reach USD 4.5 Billion by 2034 And Grow at A CAGR of 5.2%. NEWARK, DE / ACCESSWIRE / July 3, 2024 / The necrotizing fasciitis treatment ...

10. • Bioz Brings Cutting-Edge AI Citation Widgets to Precision X-Ray, Inc.'s Product Pages

      Digital Journal· 6 days ago

      ...Cultural Series Redefines AI & Visual Art in Mykonos & Bodrum GSK and CureVac to Restructure Collaboration into New Licensing Agreement...Value mRNA Pipeline Opportunities InterContinental Hotels Group PLC Announces Transaction in Own Shares - July 3 'Port of Hueneme Cares...